Search
for
Sort by
Research 61–90 of 1000+
- ES01.01 Chemotherapy is Strictly Additive to Immunotherapy
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- Review of Promising Off-Label Use of Deucravacitinib
- Molecular landscape of lung cancer: insights into therapeutic targets and clinical outcomes
- Nanomedicine-based immunotherapy for tissue regeneration
- A comparative analysis of immune privilege in pregnancy and cancer in the context of checkpoint blockade immunotherapy
- Tregs: Where We Are and What Comes Next?
- The exploration of mitochondrial‐related features helps to reveal the prognosis and immunotherapy methods of colorectal cancer
- A bibliometric analysis of T cell and atherosclerosis
- 575 INTASYL self-delivering RNAi: A flexible platform to treat dermatological malignancies
- Editors’ Picks
- Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications
- Human Liver MSCs Retain Their Basic Cellular Properties in Chronically Inflamed Liver Tissue
- Embryologic layers in dermatology: Developmental checkpoint disorders, diagnostic insight, and regenerative futures
- FOXN1 Deficiency: from the Discovery to Novel Therapeutic Approaches
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database
- Turning JAK STATic, a peek into the future of dermatology therapeutics
- The Modulatable Stem Cell Niche: Tissue Interactions during Hair and Feather Follicle Regeneration
- 801 TEC family kinase inhibitors as a novel class of therapeutics in alopecia areata
- Anais do II Congresso Nacional Acadêmico de Dermatologia
- Extracellular vesicles as precision therapeutics for psychiatric conditions: targeting interactions among neuronal, glial, and immune networks
- Aberrant Activation of the Hedgehog Pathway in Cutaneous Melanoma: Therapeutic Potential of Pharmacological Inhibitors
- Hair Follicle Immune Privilege Revisited: The Key to Alopecia Areata Management
- Association of long-term 5α-reductase inhibitor use with survival in men with renal cell carcinoma: a nationwide population-based cohort study
- Industry update: the latest developments in the field of therapeutic delivery, July 2018
- The JAK/STAT signaling pathway: from bench to clinic
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- Cellular therapeutics and immunotherapies in wound healing – on the pulse of time?
- Diverse Role of OX40 on T Cells as a Therapeutic Target for Skin Diseases